FDA Issues Import Alert on Peninsular Malaysian Shrimp

April 18, 2016

Today, the U.S. Food and Drug Administration (FDA) issued Import Alert 16-136, “Detention without Physical Examination of Aquacultured Shrimp and Prawns from Peninsular Malaysia Due to Presence of Drug Residues from Unapproved Animal Drugs or the Presence of Unsafe Food Additives.” Import Alert 16-136 follows a massive increase in the number of shrimp entry lines refused by the FDA for reasons related to veterinary drug residues beginning in 2014.